BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16314938)

  • 21. Conservative surgery and radiotherapy in the treatment of spinal cord astrocytoma.
    Jyothirmayi R; Madhavan J; Nair MK; Rajan B
    J Neurooncol; 1997 Jul; 33(3):205-11. PubMed ID: 9195492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial.
    Maranzano E; Bellavita R; Rossi R; De Angelis V; Frattegiani A; Bagnoli R; Mignogna M; Beneventi S; Lupattelli M; Ponticelli P; Biti GP; Latini P
    J Clin Oncol; 2005 May; 23(15):3358-65. PubMed ID: 15738534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postoperative radiotherapy results in primary spinal cord astrocytomas.
    Zorlu F; Ozyigit G; Gurkaynak M; Soylemezoglu F; Akyol F; Lale Atahan I
    Radiother Oncol; 2005 Jan; 74(1):45-8. PubMed ID: 15683668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of high-grade spinal cord astrocytoma of childhood with "8-in-1" chemotherapy and radiotherapy: a pilot study of CCG-945. Children's Cancer Group.
    Allen JC; Aviner S; Yates AJ; Boyett JM; Cherlow JM; Turski PA; Epstein F; Finlay JL
    J Neurosurg; 1998 Feb; 88(2):215-20. PubMed ID: 9452226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of surgery and radiation therapy on spinal high-grade gliomas: a population-based study.
    Liu J; Zheng M; Yang W; Lo SL; Huang J
    J Neurooncol; 2018 Sep; 139(3):609-616. PubMed ID: 29796723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervicomedullary tumors in children.
    McAbee JH; Modica J; Thompson CJ; Broniscer A; Orr B; Choudhri AF; Boop FA; Klimo P
    J Neurosurg Pediatr; 2015 Oct; 16(4):357-66. PubMed ID: 26114990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 patients treated with a prospective margin-directed policy.
    Livi L; Meattini I; Franceschini D; Saieva C; Meacci F; Marrazzo L; Gerlain E; Desideri I; Scotti V; Nori J; Sanchez LJ; Orzalesi L; Bonomo P; Greto D; Bianchi S; Biti G
    Radiother Oncol; 2013 Aug; 108(2):273-8. PubMed ID: 23490271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective local control of vertebral metastases by simultaneous integrated boost radiotherapy: preliminary results.
    Lubgan D; Ziegaus A; Semrau S; Lambrecht U; Lettmaier S; Fietkau R
    Strahlenther Onkol; 2015 Mar; 191(3):264-71. PubMed ID: 25395089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elderly and poor prognosis patients with high grade glioma: hypofractionated radiotherapy.
    Donato V; Monaco A; Rollo A; Messineo D; Santuari L; Castrichino A; Caiazzo R; Salvati M; Delfini R; Banelli E
    Clin Ter; 2007; 158(3):227-30. PubMed ID: 17612282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results.
    Narayana A; Yamada J; Berry S; Shah P; Hunt M; Gutin PH; Leibel SA
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):892-7. PubMed ID: 16458777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irradiation of pediatric high-grade spinal cord tumors.
    Tendulkar RD; Pai Panandiker AS; Wu S; Kun LE; Broniscer A; Sanford RA; Merchant TE
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1451-6. PubMed ID: 20346593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypofractionated stereotactic radiotherapy for low grade glioma at McGill University: long-term follow-up.
    Roberge D; Souhami L; Olivier A; Leblanc R; Podgorsak E
    Technol Cancer Res Treat; 2006 Feb; 5(1):1-8. PubMed ID: 16417396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EORTC 22972-26991/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and quality-assurance results of the stereotactic boost arm.
    Baumert BG; Brada M; Bernier J; Kortmann RD; Dehing-Oberije C; Collette L; Davis JB
    Radiother Oncol; 2008 Aug; 88(2):163-72. PubMed ID: 18455252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing incidence and improved survival of gliomas.
    Ho VK; Reijneveld JC; Enting RH; Bienfait HP; Robe P; Baumert BG; Visser O;
    Eur J Cancer; 2014 Sep; 50(13):2309-18. PubMed ID: 24972545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
    Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
    Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative radiotherapy in the management of spinal cord ependymoma.
    Whitaker SJ; Bessell EM; Ashley SE; Bloom HJ; Bell BA; Brada M
    J Neurosurg; 1991 May; 74(5):720-8. PubMed ID: 2013772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients.
    Cozzarini C; Fiorino C; Deantoni C; Briganti A; Fodor A; La Macchia M; Noris Chiorda B; Rancoita PM; Suardi N; Zerbetto F; Calandrino R; Montorsi F; Di Muzio N
    Eur Urol; 2014 Dec; 66(6):1024-30. PubMed ID: 24985964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.